Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Labetalol in Laparoscopic Cholecystectomy
NCT02997800Phase 2Completed
- Start
- Nov 2012
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of labetalol in hypertension (HTN) and tachycardia (3 arms). Primary endpoint: Length of stay in the post-anesthesia care unit. Started Nov 2012; status: completed.
02
Drugs
labetalol
03
Conditions
hypertension (HTN)tachycardia
Beyond the preview
Go deeper on NCT02997800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02997800.